Suppr超能文献

在英国亚洲人中,在停用抗惊厥药物治疗之前应筛查并治疗骨软化症。

Osteomalacia should be sought and treated before withdrawal of anticonvulsant therapy in UK Asians.

作者信息

Macallan D C, Maxwell J D, Eastwood J B

机构信息

Division of Biochemical Medicine, St. George's Hospital Medical School, London, UK.

出版信息

Postgrad Med J. 1992 Feb;68(796):134-6. doi: 10.1136/pgmj.68.796.134.

Abstract

Individuals from the Asian sub-continent in the United Kingdom are at particular risk of developing osteomalacia. We report a Gujarati woman who developed osteomalacia whilst taking anticonvulsant drugs; withdrawal of anticonvulsant therapy was followed by a seizure complicated by femoral neck fracture. In patients with other risk factors for osteomalacia, as is the case for Asians living in Britain, anticonvulsant drugs should not be reduced or withdrawn until osteomalacia, which puts the skeleton at increased risk of fracture, and its associated hypocalcaemia, which reduces seizure threshold, have been sought and adequately treated.

摘要

在英国,来自亚洲次大陆的人群患骨软化症的风险尤其高。我们报告了一名古吉拉特族女性,她在服用抗惊厥药物期间患上了骨软化症;停用抗惊厥治疗后发生了癫痫发作,并并发股骨颈骨折。对于有骨软化症其他风险因素的患者,如生活在英国的亚洲人,在未找出并充分治疗骨软化症及其相关的低钙血症(这会增加骨骼骨折风险并降低癫痫发作阈值)之前,不应减少或停用抗惊厥药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e7/2399210/9378fda94da9/postmedj00062-0060-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验